|
 | Up a level |
Zhang, Yichen, Chen, Dingyi, Fu, Mengyuan, Shi, Luwen, Naci, Huseyin 
ORCID: 0000-0002-7192-5751, Wagner, Anita Katharina, Ross, Joseph S. and Guan, Xiaodong
(2025)
Strength of evidence supporting cancer drug approvals in China, 2017-2021.
Journal of Clinical Oncology, 43 (16_suppl).
ISSN 0732-183X
Wallach, Joshua D., Ross, Joseph S. and Naci, Huseyin ORCID: 0000-0002-7192-5751
(2018)
The US Food and Drug Administration’s expedited approval programs: Evidentiary standards, regulatory trade-offs, and potential improvements.
Clinical Trials.
ISSN 1740-7745
Wallach, Joshua D., Ross, Joseph S. and Naci, Huseyin ORCID: 0000-0002-7192-5751
(2018)
The US Food and Drug Administration’s expedited approval programs: addressing premarket flexibility with enhanced postmarket evidence generation.
Clinical Trials, 15 (3).
pp. 243-246.
ISSN 1740-7745
